During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of patient treatment Overall safety profile of BRIUMVI rema ...

During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of patient treatment ...

Standout benefits: The company boasts a 94% success rate with offer-in-compromise agreements and claims to have helped ...

King's College London and Imperial College London, in collaboration with the UK MS Register, report a prevalent multiple sclerosis (MS) subtype marked by significant cognitive deficits with minimal ...

Not his fault of course, the trouble we’re all in. He seems a decent man, likeable, good values. But why do so many relate to this drivel? It deflates the soul. Play is lowest common denominator at ...

Evan Coleman is an Updates Editor on the Credit Cards and Travel Rewards team at Forbes Advisor, showcasing his interest in personal finance and love of travel. He has written for a variety of local ...

For patients with multiple myeloma who have undergone multiple lines of treatment and are refractory to common agents, new therapies offer remarkable hope. With 3 BCMA-targeted bispecific antibodies ...

Shaji Kumar, MD, Mayo Clinic, discusses the July approval of linvoseltamab, a new bispecific antibody for relapsed myeloma, ...

Our NFL Nation reporters react to all the action, answering the biggest questions coming out of each game. Here's what we ...

The latest Nintendo Switch 2 bundle can be yours for less than $600 with this deal, but it ends soon. reading time 2 minutes The Nintendo Switch 2 just dropped this past June, and it was everything ...

Mr. Edsall contributes a weekly column from Washington, D.C., on politics, demographics and inequality. President Trump is winning. Universities retreat under pressure, law firms submit to extortion, ...